# Phase 4 Psychotic Disorders trials recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in phase 4 for Psychotic Disorders that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Psychotic Disorders trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/psychotic-disorders

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 29, 2026 | NCT07615075 | Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With... | University of Maryland, Baltimore | Phase 4 | Not yet recruiting | Schizophrenia, Schizo Affective Disorder, Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615075) |
| March 19, 2026 | NCT07483294 | Cerebellum-based Imaging Neural Markers for Antipsychotic Response | Northwell Health | Phase 4 | Recruiting | Psychosis; Acute | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483294) |
| January 15, 2026 | NCT07342764 | Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial | Sultan Qaboos University | Phase 4 | Not yet recruiting | Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342764) |
| October 9, 2025 | NCT07213466 | Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder | Mayo Clinic | Phase 4 | Recruiting | Bipolar I Disorder, Bipolar II Disorder, Schizo Affective Disorder, Obesity, Weight Loss, GLP - 1 | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07213466) |
| August 5, 2025 | NCT07105111 | A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While... | Neurocrine Biosciences | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depressive Disorder, Tardive Dyskinesia | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07105111) |
| June 3, 2025 | NCT07001878 | Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis | Nova Scotia Health Authority | Phase 4 | Not yet recruiting | Psychosis, Cannabis Use | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001878) |
| December 18, 2024 | NCT06740890 | Exercise and Olanzapine-samidorphan | New York State Psychiatric Institute | Phase 4 | Recruiting | Schizophenia Disorder, Schizoaffective Disorder, Bipolar Disorder I or II, Bipolar Disorder NOS | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06740890) |
| October 10, 2024 | NCT06634641 | Clozapine-related Immunodeficiency in Parkinsons Disease | Centre Hospitalier Universitaire, Amiens | Phase 4 | Recruiting | Clozapine, Parkinson&#39;s Disease (PD), Immunodeficiency, Psychosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06634641) |
| August 20, 2024 | NCT06562608 | Anticholinergic Deprescription in Schizophrenia | Sponsor not shown (see the record) | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06562608) |
| August 9, 2024 | NCT06546475 | A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine | National Taiwan University Hospital | Phase 4 | Not yet recruiting | Psychosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06546475) |
| December 18, 2023 | NCT06174116 | Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia | University of Massachusetts, Worcester | Phase 4 | Recruiting | Schizophrenia, Schizo Affective Disorder | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06174116) |
| July 25, 2023 | NCT05958875 | The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a... | Sponsor not shown (see the record) | Phase 4 | Recruiting | Schizophrenia and Related Disorders, Early Treatment-Resistance | 418 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05958875) |
| October 21, 2022 | NCT05590637 | Comparing Antipsychotic Medications in LBD Over Time | The University of Texas Health Science Center at San Antonio | Phase 4 | Recruiting | Parkinson's Disease Psychosis, Dementia With Lewy Bodies | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05590637) |
| April 7, 2022 | NCT05316883 | Biomarkers in Clozapine-responding Schizophrenia | Sponsor not shown (see the record) | Phase 4 | Recruiting | Schizophrenia, Psychosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05316883) |
| March 16, 2022 | NCT05282277 | Examining the Effects of Estradiol on Neural and Molecular Response to Reward | University of North Carolina, Chapel Hill | Phase 4 | Recruiting | Depression, Psychosis, Anhedonia | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05282277) |
| January 26, 2022 | NCT05208190 | Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial | New York State Psychiatric Institute | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder | 280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05208190) |
| October 8, 2020 | NCT04580134 | CLOZAPINE Response in Biotype-1 | University of Texas Southwestern Medical Center | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder | 524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04580134) |
| October 3, 2019 | NCT04113993 | Bazedoxifene -Treatment for Women With Schizophrenia | Sponsor not shown (see the record) | Phase 4 | Recruiting | Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04113993) |
| April 11, 2018 | NCT03495024 | Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates | Corporal Michael J. Crescenz VA Medical Center | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder, Tobacco Smoking, Tardive Dyskinesia, Parkinsonism | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03495024) |
| December 24, 2015 | NCT02639702 | Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia | Centre for Addiction and Mental Health | Phase 4 | Recruiting | Schizophrenia, Schizoaffective Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02639702) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| New York State Psychiatric Institute | 2 |
| Nova Scotia Health Authority | 1 |
| University of Maryland, Baltimore | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Mayo Clinic | 1 |
| Centre for Addiction and Mental Health | 1 |
| University of North Carolina, Chapel Hill | 1 |
| National Taiwan University Hospital | 1 |
| Northwell Health | 1 |
| Corporal Michael J. Crescenz VA Medical Center | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| University of Massachusetts, Worcester | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Sultan Qaboos University | 1 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 12 |
| Canada | 2 |
| Denmark | 1 |
| Australia | 1 |
| Austria | 1 |
| Germany | 1 |
| Italy | 1 |
| Spain | 1 |
| United Kingdom | 1 |
| France | 1 |
| Oman | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Threads and yarns wholesalers in the United States](https://specstream.ai/data/businesses/threads-and-yarns-wholesalers/united-states)
- [Suppliers and distributors in the United States](https://specstream.ai/data/businesses/suppliers-and-distributors/united-states)
- [Social security law firms in the United States](https://specstream.ai/data/businesses/social-security-law-firms/united-states)
- [Sandblasting companies in the United States](https://specstream.ai/data/businesses/sandblasting-companies/united-states)
- [Ramen restaurants in the United States](https://specstream.ai/data/businesses/ramen-restaurants/united-states)
- [Private jet charter companies in the United States](https://specstream.ai/data/businesses/private-jet-charter-companies/united-states)
